» Articles » PMID: 37342183

Colorectal Polyps Increase the Glycolytic Activity

Overview
Journal Front Oncol
Specialty Oncology
Date 2023 Jun 21
PMID 37342183
Authors
Affiliations
Soon will be listed here.
Abstract

In colorectal cancer (CRC) energy metabolism research, the precancerous stage of polyp has remained rather unexplored. By now, it has been shown that CRC has not fully obtained the glycolytic phenotype proposed by O. Warburg and rather depends on mitochondrial respiration. However, the pattern of metabolic adaptations during tumorigenesis is still unknown. Understanding the interplay between genetic and metabolic changes that initiate tumor development could provide biomarkers for diagnosing cancer early and targets for new cancer therapeutics. We used human CRC and polyp tissue material and performed high-resolution respirometry and qRT-PCR to detect changes on molecular and functional level with the goal of generally describing metabolic reprogramming during CRC development. Colon polyps were found to have a more glycolytic bioenergetic phenotype than tumors and normal tissues. This was supported by a greater , , , and expression. Despite the increased glycolytic activity, cells in polyps were still able to maintain a highly functional OXPHOS system. The mechanisms of OXPHOS regulation and the preferred substrates are currently unclear and would require further investigation. During polyp formation, intracellular energy transfer pathways become rearranged mainly by increasing the expression of mitochondrial adenylate kinase () and creatine kinase () isoforms. Decreased glycolysis and maintenance of OXPHOS activity, together with the downregulation of the CK system and the most common AK isoforms ( and ), seem to play a relevant role in CRC development.

Citing Articles

Energy Metabolism Profiling of Human Colorectal Tumours.

Reinsalu L, Miller S, Auditano G, Puurand M, Moreno-Sanchez R, Saavedra E J Cell Mol Med. 2025; 29(5):e70462.

PMID: 40045444 PMC: 11882391. DOI: 10.1111/jcmm.70462.


hnRNPH1 maintains mitochondrial homeostasis by establishing NRF1/DRP1 retrograde signaling under mitochondrial stress.

Zhao L, Zou X, Deng J, Sun B, Li Y, Zhao L Cell Death Differ. 2024; 32(1):118-133.

PMID: 38898233 PMC: 11742414. DOI: 10.1038/s41418-024-01331-4.


Comprehensive multiomics analysis reveals distinct differences between pediatric choroid plexus papilloma and carcinoma.

Choi Y, Choi S, Koh E, Yun I, Park S, Jeon S Acta Neuropathol Commun. 2024; 12(1):93.

PMID: 38867333 PMC: 11167863. DOI: 10.1186/s40478-024-01814-y.

References
1.
Klepinin A, Zhang S, Klepinina L, Rebane-Klemm E, Terzic A, Kaambre T . Adenylate Kinase and Metabolic Signaling in Cancer Cells. Front Oncol. 2020; 10:660. PMC: 7248387. DOI: 10.3389/fonc.2020.00660. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Robey R, Hay N . Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene. 2006; 25(34):4683-96. DOI: 10.1038/sj.onc.1209595. View

4.
Giles R, Lolkema M, Snijckers C, Belderbos M, van der Groep P, Mans D . Interplay between VHL/HIF1alpha and Wnt/beta-catenin pathways during colorectal tumorigenesis. Oncogene. 2006; 25(21):3065-70. DOI: 10.1038/sj.onc.1209330. View

5.
Puurand M, Tepp K, Timohhina N, Aid J, Shevchuk I, Chekulayev V . Tubulin βII and βIII Isoforms as the Regulators of VDAC Channel Permeability in Health and Disease. Cells. 2019; 8(3). PMC: 6468622. DOI: 10.3390/cells8030239. View